NCT06152042Phase 2Completed

Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus

Study sponsor: Biomea Fusion Inc. · BMEA

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2025-05-20Actual
Enrollment · participants37Actual
Source updated2026-08-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Terminated. After: Completed.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview